CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. AVAV
3. NVDA
4. DLR
5. EOSE
6. NKE
7. MU
8. AAPL
9. TSLA
10. VSH

Go back to CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.04 -0.04 (3.7%)
Previous Close $1.08    52 Week High $0.66 
Open $1.11    52 Week Low $0.20 
Day High $1.13    P/E N/A 
Day Low $1.03    EPS $-0.34 
Volume 241,279